Table 2 Summary of adverse events
Prasugrel | Placebo | |
|---|---|---|
(n = 41) | (n = 19) | |
Any hemorrhagic event, n (%) | ||
Required medical attention | 0 | 0 |
Treatment-emergent | 8 (19.5) | 1 (5.3) |
Possibly related to study drug | 6 (14.6) | 1 (5.3) |
Any non-hemorrhagic event, n (%) | ||
Serious | 8 (19.5) | 4 (21.1) |
Study drug discontinuation | 2 (4.9) | 0 |
Treatment-emergent | 31 (75.6) | 17 (89.5) |
Possibly related to study drug | 2 (4.9) | 0 |
Any event, n (%) | ||
Serious | 8 (19.5) | 4 (21.1) |
Study drug discontinuation | 2 (4.9) | 0 |
Treatment emergent | 34 (82.9) | 17 (89.5) |
Possibly related to study drug | 8 (19.5) | 1 (5.3) |